Lee Ainslie Spring Works Therapeutics, Inc. Put Options Transaction History
Maverick Capital LTD
- $4.82 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding SWTX
# of Institutions
237Shares Held
68.9MCall Options Held
144KPut Options Held
257K-
Vanguard Group Inc Valley Forge, PA6.71MShares$249 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.62MShares$209 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT3.84MShares$143 Million4.54% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.52MShares$131 Million0.01% of portfolio
-
Boxer Capital, LLC San Diego, CA3.42MShares$127 Million5.82% of portfolio
About SpringWorks Therapeutics, Inc.
- Ticker SWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,401,100
- Market Cap $2.32B
- Description
- SpringWorks Therapeutics, Inc. acquires, develops, and commercializes medicines for underserved patient populations suffering from rare diseases and cancer. Its lead product candidate is nirogacestat, an oral small molecule gamma secretase inhibitor that is in Phase III clinical trial for the treatment of desmoid tumors. The company is also deve...